Cancer Prognosis According to Parthanatos Features

Messikomer, A; Bruktawit, M; Seipel, Katja; Valk, P; Theocharides, A; Pabst, Thomas; Mckeague, M; Luedtke, N (25 May 2021). Cancer Prognosis According to Parthanatos Features (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2021.05.24.445484

[img] Text
2021.05.24.445484v1.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB)

Messikommer and co-workers report that PARP-1-mediated programmed cell death is associated with successful, front-line treatment of acute myeloid leukemia (AML).

Item Type:

Working Paper

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Seipel, Katja, Pabst, Thomas Niklaus

Subjects:

600 Technology > 610 Medicine & health

Series:

bioRxiv

Publisher:

Cold Spring Harbor Laboratory

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

24 Jan 2022 14:47

Last Modified:

05 Dec 2022 16:02

Publisher DOI:

10.1101/2021.05.24.445484

BORIS DOI:

10.48350/164185

URI:

https://boris.unibe.ch/id/eprint/164185

Actions (login required)

Edit item Edit item
Provide Feedback